RESUMO
Squamous cell carcinoma in situ on the penis has been reported to have variable success and morbidity. A 71-year-old male patient with the condition was successfully treated with a topical application of 5% imiquimod cream, three times a week for 4 weeks. A biopsy specimen was obtained to confirm tumor clearance. There was no clinical evidence of any residual tumor 3 months after the therapy was completed. There was also no evidence of scarring, deformity or systemic side effects.
Assuntos
Idoso , Humanos , Masculino , Biópsia , Carcinoma de Células Escamosas , Cicatriz , Anormalidades Congênitas , Neoplasia Residual , PênisRESUMO
Condyloma acuminatum, an infection caused by human papilloma virus, is one of the most common sexually transmitted diseases involving the anogenital area. Although it has been more common in adults, the incidence in children has been increasing recently. Although several treatment options are available for condyloma in adults, children's treatment options are limited because non-painful alternatives should be considered as first-line therapy. Imiquimod cream is an immunomodulating agent that has been demonstrated to be a potent inducer of several cytokines promoting an antiviral cell-mediated immune response. Herein, we report two cases of condyloma acuminata in children which showed an excellent response to 5% imiquimod cream without any adverse reactions.